Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 4:31 pm Sale | 2025-12-31 | 13G | MEIRAGTX HLDGS PLC MGTX | Prosight Management, LP | 3,211,788 4.000% | -1,144,783 (-26.28%) | Filing History |
| 2026-02-13 4:31 pm Purchase | 2025-12-31 | 13G | ADC THERAPEUTICS SA SHS ADCT | Prosight Management, LP | 8,477,338 6.800% | 1,281,964 (+17.82%) | Filing History |
| 2026-02-06 4:23 pm Purchase | 2026-02-03 | 13G | JANUX THERAPEUTICS INC JANX | Prosight Management, LP | 3,157,220 5.300% | 3,157,220 (New Position) | Filing History |
| 2025-11-28 08:15 am Purchase | 2025-11-24 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Prosight Management, LP | 745,649 5.800% | 745,649 (New Position) | Filing History |
| 2025-11-13 7:39 pm Sale | 2025-09-30 | 13G | MURAL ONCOLOGY PUB LTD CO MURA | Prosight Management, LP | 0 0.000% | -900,000 (Position Closed) | Filing History |
| 2025-11-13 7:38 pm Sale | 2025-09-30 | 13G | ADC THERAPEUTICS SA SHS ADCT | Prosight Management, LP | 7,195,374 5.800% | -2,422,157 (-25.18%) | Filing History |
| 2025-11-13 7:38 pm Sale | 2025-09-30 | 13G | SHATTUCK LABS INC STTK | Prosight Management, LP | 6,543,240 9.900% | -141,660 (-2.12%) | Filing History |
| 2025-06-26 5:26 pm Purchase | 2025-06-23 | 13G | MURAL ONCOLOGY PUB LTD CO MURA | Prosight Management, LP | 900,000 5.200% | 900,000 (New Position) | Filing History |
| 2025-05-14 08:30 am Purchase | 2025-03-31 | 13G | MEIRAGTX HLDGS PLC MGTX | Prosight Management, LP | 4,356,571 5.400% | 303,857 (+7.50%) | Filing History |
| 2025-02-12 08:30 am Purchase | 2024-12-31 | 13G | VINCERX PHARMA INC VINC | Prosight Management, LP | 111,755 4.990% | 27,823 (+33.15%) | Filing History |
| 2024-11-13 08:58 am Sale | 2024-09-30 | 13G | ADC THERAPEUTICS SA SHS ADCT | Prosight Management, LP | 9,617,531 9.950% | -9,486 (-0.10%) | Filing History |
| 2024-11-13 08:32 am Sale | 2024-09-30 | 13G | VINCERX PHARMA, INC VINC | Prosight Management, LP | 83,932 5.000% | -40,929 (-32.78%) | Filing History |
| 2024-11-13 08:30 am Purchase | 2024-09-30 | 13G | ADC THERAPEUTICS SA SHS ADCT | Prosight Management, LP | 9,627,017 9.960% | 3,155,217 (+48.75%) | Filing History |
| 2024-11-13 08:30 am Purchase | 2024-09-30 | 13G | SHATTUCK LABS INC STTK | Prosight Management, LP | 6,684,900 14.000% | 1,314,900 (+24.49%) | Filing History |
| 2024-08-16 7:16 pm Purchase | 2024-08-14 | 13G | SHATTUCK LABS INC STTK | Prosight Management, LP | 5,370,000 11.300% | 2,587,203 (+92.97%) | Filing History |
| 2024-05-03 09:00 am Purchase | 2024-04-25 | 13G | VINCERX PHARMA, INC VINC | Prosight Management, LP | 124,861 9.100% | 124,861 (New Position) | Filing History |
| 2024-02-13 09:55 am Sale | 2023-12-31 | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Prosight Management, LP | 0 0.000% | -948,012 (Position Closed) | Filing History |
| 2024-02-13 09:54 am Sale | 2023-12-31 | 13G | MEIRAGTX HLDGS PLC MGTX | Prosight Management, LP | 4,052,714 6.400% | -28,090 (-0.69%) | Filing History |
| 2024-02-13 09:50 am Sale | 2023-12-31 | 13G | KEZAR LIFE SCIENCES INC KZR | Prosight Management, LP | 336,533 4.600% | -70,790 (-17.38%) | Filing History |
| 2024-02-13 09:50 am Sale | 2023-12-31 | 13G | NANOSTRING TECHNOLOGIES INC CO NSTGQ | Prosight Management, LP | 0 0.000% | -3,150,000 (Position Closed) | Filing History |